Positive Phase 1 Data for Blue Lake BiotechnologyĢƵ Intranasal RSV Vaccine Published in Science Advances
ATHENS, Ga. & LOS GATOS, Calif.--(BUSINESS WIRE)--Oct 25, 2023--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing PIV5-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, announced ...
